NASDAQ: TCRTAlaunos Therapeutics Inc Stock Ownership - Who owns Alaunos Therapeutics?
Insider buying vs selling
Have Alaunos Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert W. Postma | Director | 2025-04-13 | 20,804 | $2.92 | $60.75kBuy |
| Robert W. Postma | Director | 2025-04-13 | 20,804 | $2.92 | $60.75kBuy |
| Jaime Vieser | Director | 2024-12-31 | 2,182 | $2.01 | $4.39kSell |
| Jaime Vieser | Director | 2024-12-31 | 818 | $2.00 | $1.64kSell |
TCRT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TCRT insiders and whales buy or sell their stock.
TCRT Shareholders
What type of owners hold Alaunos Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Randal J. Kirk | 503.71% | 11,056,069 | $30.07M | Insider |
| Robert W. Postma | 198.31% | 4,352,721 | $11.84M | Insider |
| Essex Woodlands Health Ventures Fund VI L P | 108.05% | 2,371,642 | $6.45M | Insider |
| Laurence James Neil Cooper | 81.97% | 1,799,280 | $4.89M | Insider |
| Paloma International L P | 55.33% | 1,214,456 | $3.30M | Insider |
| Lindsay A. Md Rosenwald | 55.33% | 1,214,455 | $3.30M | Insider |
| Kevin S. Boyle Sr. | 36.37% | 798,236 | $2.17M | Insider |
| Jonathan 1. Lewis | 33.92% | 744,595 | $2.03M | Insider |
| James Anthony Cannon | 18.13% | 398,050 | $1.08M | Insider |
| Timothy McInerney | 16.95% | 372,120 | $1.01M | Insider |
TCRT vs Biotech Stocks
Alaunos Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.